Covidien Ltd. (NYSE:COV)
The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Competition from isrg
Recs
Recs
Great management. Good PE and solid dividend. Investing heavily in R and D.
Recs
In the forefront of developing,acquiring,marketing and execution....
What else you want ? The COV team is doing all the
right moves to bring COV higher with respectable P:E:,P:S,Cash Flow (after cap ex).
Recs
The public needs training in their ability to evaluate stocks as per experience.
Recs
Good management, favorable environment.
Recs
More growth, higher margins post spin-off of pharma
Recs
Picked on the recommendation of TMFdeej
Recs
Covidien is a company that I've had my eye on for a while, ever since it was spun off from Tyco. It hasn't done much but bounce around since then. It just announced that it plans to split its medical device and pharma businesses. I like the move.
Deej
Recs
Recs
Baby Boomers.
Recs
Mechanical formula YLDEARNYEAR2
Recs
key03, 1.4% annual dividend
Recs
s&P 5 star. 1.4 div
Recs
50 crossing 200 strong fundamentals
Recs
Raymond James Picks 2011
Recs
Growth in 5 to 10 years. Probably longer. Medical devices medical devices medical devices... we'll all be needing them and they're leading the niche markets, sopping up whatever they can that looks valuable.
Recs
Stock Picker - 5 Star, Pays Dividend, Down at Least 20% over last 12 months
Recs
Has the look of value
Recs
This is a very strong company with very little debt. They are also leaders in the areas they serve.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 46 : 1 2 3 Next »